EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Spatiotemporally Controlled Tumor Photodynamic/Immunotherapy Therapy Based on Upconversion Hybrid Nanosystem

Fang Wang, Wenfei Xu, Yuechen Liu, Shuxuan Zhu, Wenjing Liu, Shuhui Bo, Hong Sun, Bei Liu, Zhaogang Sun, Hongqian Chu iD

Advanced Science · 2026

DOI: 10.1002/advs.202515052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Fang Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Translational Medicine Center, Beijing Chest Hospital, Capital Medical University & Beijing Tuberculosis and Thoracic Tumor Research Institute, Beiji…. Hauptthemen laut MEDLINE: Photochemotherapy, Immunotherapy, Nanoparticles, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Capital Medical University Outstanding Young Talents Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy holds great promise for cancer treatment, but its clinical application is hindered by the immunosuppressive tumor microenvironment (TME) and the systematic toxicity. Herein, a spatiotemporally controllable smart nanodevice based on upconversion nanoparticles (UCNPs) that can be activated by dual near ‐ infrared (NIR) light for tumor immunotherapy, namely PURH, is developed. PURH is constructed by a five‐layer UCNPs surface coated with mesoporous silica, which encapsulates the photosensitizer rose bengal (RB) within the mesoporous channels. Additionally, CpG oligonucleotides (CpG ODN) is linked to the surface, followed by the surface functionalization of hyaluronic acid (HA) to achieve tumor targeting. PURH allows for dual NIR light activation, where 980 nm NIR light irradiation activates photodynamic therapy (PDT), inducing apoptosis and immunogenic cell death (ICD), while 808 nm NIR light irradiation triggers the release of CpG for tumor immunotherapy. The study offers a powerful tool and strategy for spatiotemporal controlled tumor immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyImmunotherapyNanoparticlesNeoplasmsAnimalsMicePhotosensitizing AgentsHumansTumor MicroenvironmentRose BengalCell Line, TumorApoptosisOligodeoxyribonucleotides

Stichwörter der Autor:innen

immunotherapyphotodynamic therapytumorupconversion nanoparticles

Substanzen

Photosensitizing AgentsRose BengalCPG-oligonucleotideOligodeoxyribonucleotides

Autor:innen und Institutionen

  • Translational Medicine Center, Beijing Chest Hospital, Capital Medical University & Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, China.
  • College of Science, Minzu University of China, Beijing, 100081, China.

ORCID-Profile: Hongqian Chu

Förderung

  • Capital Medical University Outstanding Young Talents Project

Zitieren

APA

Wang, F., Xu, W., Liu, Y., Zhu, S., Liu, W., Bo, S., Sun, H., Liu, B., Sun, Z., & Chu, H. (2026). Spatiotemporally Controlled Tumor Photodynamic/Immunotherapy Therapy Based on Upconversion Hybrid Nanosystem. Advanced Science. https://doi.org/10.1002/advs.202515052

Vancouver

Wang F, Xu W, Liu Y, Zhu S, Liu W, Bo S, et al. Spatiotemporally Controlled Tumor Photodynamic/Immunotherapy Therapy Based on Upconversion Hybrid Nanosystem. Advanced Science. 2026. doi:10.1002/advs.202515052

BibTeX
@article{Wang2026,
  author = {Wang, Fang and Xu, Wenfei and Liu, Yuechen and Zhu, Shuxuan and Liu, Wenjing and Bo, Shuhui and Sun, Hong and Liu, Bei and Sun, Zhaogang and Chu, Hongqian},
  title = {Spatiotemporally Controlled Tumor Photodynamic/Immunotherapy Therapy Based on Upconversion Hybrid Nanosystem},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202515052}
}
Kostenlos starten →